This protocol covers the management of Ebola virus disease presenting with haemorrhagic manifestations — specifically, active bleeding in the context of haemodynamic instability or a haemoglobin level below 7 g/dl. Early recognition and targeted resuscitation are critical in this high-acuity presentation.
The protocol applies to patients with confirmed Ebola virus disease who develop active bleeding accompanied by haemodynamic instability or low haemoglobin (< 7 g/dl). Transfusion is considered when either of these criteria is met.
Consider transfusion if active bleeding and haemodynamic instability or Hb < 7 g/dl.
The approach centres on securing vascular access, correcting haematological deficits through blood product transfusion to defined targets, and administering adjunctive haemostatic agents — the complete regimen, agent selection, and full dosing sequence are available in the structured protocol.